ESC Professional Premium Access

Autoimmune, chronic inflammatory disorders, HIV and cardiovascular disease

Event: ESC Congress 2022
Topic: Cardiovascular Disease in Special Populations
Session type: Moderated ePosters
Date: 26 August 2022
Time: 08:15 - 08:55

Congress Session

6 presentations in this session

Everolimus-eluting bioresorabable scaffold system in the treatment of cardiac allograft vasculopathy: the cardiac allograft reparative therapy (CART) prospective multicentre pilot study

Speaker: Doctor S. Fezzi (Galway, IE)

Takotsubo's cardiomyopathy in patients with pre-existing autoimmune diseases : a national inpatient sample analysis

Speaker: Doctor S. Kannayiram (Chicago, US)

Dissecting genetics in hypothyroidism as an independent risk factor in atherosclerotic disease

Speaker: Mr S. Rand (Copenhagen, DK)

Endothelial glycocalyx improvement after six months and one-year of antiretroviral therapy in treatment naive patients with human immunodeficiency virus

Speaker: Doctor H. Triantafyllidi (Athens, GR)

Abnormal immune activation and fibrosis of epicardial adipose tissue in people living with HIV: results from the PIECVIH study.

Speaker: Professor F. Boccara (Paris, FR)

Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment - preliminary findings of participants co-enrolled into the StatinTB trial and Cardiac Imaging After TB (CIA-TB) study

Speaker: Doctor S. Mukasa (Cape Town, ZA)

6 speakers from this session

Doctor Simone Fezzi

Galway University Hospital, Galway (Ireland)
0 follower

Doctor Sandhya Kannayiram

John H. Stroger Jr. Hospital of Cook County, Chicago (United States of America)
0 follower

Mr Soren Rand

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Helen Triantafyllidi

Attikon University Hospital, Athens (Greece)
0 follower

Professor Franck Boccara

Hospital Saint-Antoine, Paris (France)
0 follower

Doctor Sandra Mukasa

University of Cape Town, Cape Town (South Africa)
0 follower

This platform is supported by

logo Novo Nordisk